Table 1.

Cohort characteristics

Characteristics	LERIC Study Cohort	Range	Percentage
All patients
No. of patients starting RRT	249
Median age (yr) of survivors in 2010	39.9	20.9–52.4
Median age (yr) at start of RRT	11.2	1.9–15.0
Median time (yr) on RRT	25.3	0.3–39.3
Median time (yr) with transplant	19.7	0.0–39.3
Median time (yr) on dialysis	5.6	0.0–36.5
Deaths
No. of deaths	95		38.2
Median age (yr) at death	22.7	4.2–46.3
Median time (yr) on RRT at death	11.0	0.3–32.3
Median time (yr) after first transplant at death	14.4	0.0–29.7
Cause of death
Cardiovascular	29		30.5
Infection	29		30.5
Malignancy	12		12.6
Other	23		24.5
Unknown	2		2.1
Recipients of transplants
No. of recipients of transplants	231
Median age (yr) at first transplant	12.7	3.9–23.1
Median time (yr) on RRT	26.1	1.5–39.9
Median time (yr) with transplant	19.7	0.0–39.3
Median time (yr) on dialysis	3.1	0.0–36.5
Recipients of transplants developing malignancy
No. of recipients of transplants developing malignancy	53
Median age (yr) at first malignancy	33.5	11.0–49.0
Median time (yr) on RRT at development of first malignancy	25.0	1.3–37.8
Median time (yr) with transplant at development of first malignancy	18.4	0.0–37.2
Median time (yr) on dialysis at development of first malignancy	3.3	0.0–36.5
Malignancies
No. of de novo malignancies	105

LERIC Study, Late Effects of Renal Insufficiency Study.